China National Accord Medicines Corp Ltd Market Cap ($1.49 Billion)
Market Cap & Net Worth: China National Accord Medicines Corp Ltd (000028)
China National Accord Medicines Corp Ltd market cap. China National Accord Medicines Corp Ltd (SHE:000028) has a market capitalization of $1.49 Billion (CN¥10.20 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #6966 globally and #1369 in its home market, demonstrating a 2.14% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying China National Accord Medicines Corp Ltd's stock price CN¥21.02 by its total outstanding shares 485213797 (485.21 Million). Also see China National Accord Medicines Corp Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
China National Accord Medicines Corp Ltd Market Cap History (2015–2026)
China National Accord Medicines Corp Ltd market cap history from 2015 to 2026. Data shows change from $3.21 Billion to $1.49 Billion (-6.60% CAGR). Check 000028 stock price for real-time trading data and today's change.
China National Accord Medicines Corp Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how China National Accord Medicines Corp Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore China National Accord Medicines Corp Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.03x
China National Accord Medicines Corp Ltd's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.23x
China National Accord Medicines Corp Ltd's market cap is 3.23 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.21 Billion | $37.82 Billion | $927.61 Million | 0.08x | 3.46x |
| 2016 | $3.26 Billion | $41.25 Billion | $1.19 Billion | 0.08x | 2.75x |
| 2017 | $2.95 Billion | $41.26 Billion | $1.06 Billion | 0.07x | 2.79x |
| 2018 | $2.04 Billion | $43.12 Billion | $1.21 Billion | 0.05x | 1.69x |
| 2019 | $2.26 Billion | $52.79 Billion | $1.27 Billion | 0.04x | 1.78x |
| 2020 | $2.31 Billion | $59.65 Billion | $1.40 Billion | 0.04x | 1.65x |
| 2021 | $1.90 Billion | $68.36 Billion | $1.34 Billion | 0.03x | 1.42x |
| 2022 | $1.73 Billion | $73.44 Billion | $1.49 Billion | 0.02x | 1.16x |
| 2023 | $2.02 Billion | $75.48 Billion | $1.60 Billion | 0.03x | 1.26x |
| 2024 | $2.08 Billion | $74.38 Billion | $642.49 Million | 0.03x | 3.23x |
Competitor Companies of 000028 by Market Capitalization
Companies near China National Accord Medicines Corp Ltd in the global market cap rankings as of November 1, 2026. Also see China National Accord Medicines Corp Ltd balance sheet assets for a full breakdown of the balance sheet.
Key companies related to China National Accord Medicines Corp Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #248 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #451 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #626 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.30 Billion USD ( AU$31.51 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #248 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $994.58 |
| #451 | Cencora Inc. | NYSE:COR | $61.32 Billion | $330.84 |
| #626 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $250.48 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.30 Billion | AU$2.73 |
Market Capitalization of China National Accord Medicines Corp Ltd (2015–2026)
Market capitalization of China National Accord Medicines Corp Ltd from 2015 to today. Between 2015 and today, China National Accord Medicines Corp Ltd's market cap moved from $3.21 Billion to $ 1.49 Billion, with a yearly change of -6.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.49 Billion | -14.41% |
| 2025 | CN¥1.74 Billion | -16.03% |
| 2024 | CN¥2.08 Billion | +3.03% |
| 2023 | CN¥2.02 Billion | +16.66% |
| 2022 | CN¥1.73 Billion | -9.23% |
| 2021 | CN¥1.90 Billion | -17.54% |
| 2020 | CN¥2.31 Billion | +2.24% |
| 2019 | CN¥2.26 Billion | +10.56% |
| 2018 | CN¥2.04 Billion | -30.82% |
| 2017 | CN¥2.95 Billion | -9.56% |
| 2016 | CN¥3.26 Billion | +1.64% |
| 2015 | CN¥3.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of China National Accord Medicines Corp Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.49 Billion USD |
| MoneyControl | $1.49 Billion USD |
| MarketWatch | $1.49 Billion USD |
| marketcap.company | $1.49 Billion USD |
| Reuters | $1.49 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Weste… Read more